Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Interleukin 17 receptor A (IL-17RA), also known as CDw217, is a type I membrane glycoprotein and a member of the cytokine receptor family. It serves as the primary receptor for interleukin 17A (IL-17A), a proinflammatory cytokine secreted by activated T lymphocytes. Binding of proinflammatory cytokines like interleukin 17A to this receptor triggers conformational changes that allow recruitment of adaptor proteins such as Act1 or TRAF proteins, leading to activation of NF‐κB, MAPK, and C/EBP pathways, resulting in increased production of inflammatory mediators.
Blocking or inhibiting the activity/signaling through IL-17RA
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interleukin 17 Receptor A (IL-17RA).